Causes of oocyte vitrification and its value in assisted reproductive technology.
10.12122/j.issn.1673-4254.2019.07.03
- Author:
Jing ZHE
1
;
Jun ZHANG
1
;
Shiling CHEN
1
;
Weiqing ZHANG
1
;
Chen LUO
1
;
Xingyu ZHOU
1
;
Xin CHEN
1
;
Zhuolin QIU
1
;
Huixi LI
1
;
Xiaomin WU
1
Author Information
1. Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
- Publication Type:Journal Article
- Keywords:
assisted reproductive technology;
oocytes;
vitrification
- MeSH:
Adult;
Cryopreservation;
Embryo Transfer;
Female;
Humans;
Male;
Oocytes;
Pregnancy;
Pregnancy Rate;
Retrospective Studies;
Vitrification
- From:
Journal of Southern Medical University
2019;39(7):766-771
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the causes of oocyte vitrification and its application in assisted reproduction.
METHODS:We retrospectively analyzed the data of 26 patients with 27 cycles of oocyte vitrification cryopreservation undergoing intracytoplasmic sperm injection (ICSI) and embryo transfer between January, 2008 and October, 2018. The causes of oocyte vitrification and the outcomes of ICSI and clinical pregnancy were analyzed.
RESULTS:The causes of oocytes vitrification included mainly azoospermia or severe spermatogenesis disorder of the husband, failure to obtain sperms from the husband, failure of the husband to be present on the day of oocyte retrieval and acute diseases of the husband to not allow sperm collection. A total of 274 oocytes were frozen in 27 oocyte retrieval cycles, and 217 eggs were thawed in 19 cycles with a survival rate of 81.11% (176/217). The normal fertilization rate, cleavage rate and high-quality embryo rate was 74.81% (98/131), 89.80% (88/98) and 36.73% (36/98), respectively. Fifteen patients underwent embryo transfer, and the clinical pregnancy rate and live birth rate was 53.33% (8/15) and 33.33% (5/15), respectively. Compared with patients below 35 years of age, the patients aged above 35 years had significantly lower oocyte survival rate after thawing (82.76% 74.42%, =0.211), clinical pregnancy rate (77.78% 16.67%, =0.041) and live birth rate (55.56% 0, =0.044).
CONCLUSIONS:Oocytes vitrification can be used as a remedy for infertile couples who fail to provide sperms due to male factors on the day of oocyte retrieval. Vitrification of the oocytes does not significantly affect the fertilization rate or the clinical pregnancy rate. The survival rate of the thawed oocytes is related to the age of the wife, and an age younger than 35 years can be optimal for achieving favorable clinical pregnancy outcomes after oocyte vitrification.
